2020 Financials

Statement of Financial Position

Assets Total 2020 Total 2019
Cash and Cash Equivalents $12,346,871 $12,481,416
Investments $11,413,876 $10,857,778
Contributions Receivable (Net) $13,225,054 $19,744,931
Prepaid Expenses and Other Assets $69,028 $108,594
TOTAL ASSETS $37,054,829 $43,192,719
Liabilities Total 2019 Total 2019
Accounts Payable $88,858 $139,414
Grants Payable (Net) $13,640,454 $12,248,645
Deferred Revenue $202,000 $285,000
Due to Affiliate $12,976 $137,174
TOTAL LIABILITIES $13,944,288 $12,810,233
Net Assets Total 2020 Total 2019
Unrestricted $16,890,540 $17,045,668
Temporarily Restricted $6,220,001 $13,336,818
TOTAL NET ASSETS $23,110,541 $30,382,486
TOTAL LIABILITIES AND NET ASSETS $37,054,829 $43,192,719

Statement of Activities

Revenue & Expense Statement
Revenue Total 2020 Total 2019
Contributions (Collectible Net) $5,963,431 $2,562,352
Special Events (Net) $1,382,366 $18,753,320
Sponsorship $413,256 $490,000
Interest/Investment $586,718 $820,089
In Kind Contributions $76,859 $399,679
Other Income ($1,094) $32,061
TOTAL REVENUE $8,421,536 $23,057,501
Expenses Total 2020 Total 2019
Research Grants $12,549,005 $9,265,006
Personnel Costs $1,734,967 $1,592,119
Travel & Entertainment $288,349 $384,245
Other Expenses $484,052 $364,228
Meetings & Conferences $254,294 $253,609
Professional Fees $219,379 $171,928
Occupancy $163,426 $167,995
TOTAL EXPENSES $15,693,481 $12,199,130
NET INCOME/(LOSS) ($7,271,945) $10,858,371

Financial presentation based on MRA’s 2020 externally audited financials. Full audit and IRS 990 are available online at curemelanoma.org/about-mra/financials/

MRA Functional Expenses